mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a form of proliferative arrest triggered in response to a wide variety of stimuli and characterized by unique changes in cell morphology and function. Although unable to divide, senescent cells remain metabolically active and acquire the ability to produce and secrete bioactive molecules, some of which have recognized pro-inflammatory and/or pro-tumorigenic actions. As expected, this “senescence-associated secretory phenotype (SASP)” accounts for most of the non-cell-autonomous effects of senescent cells, which can be beneficial or detrimental for tissue homeostasis, depending on the context. It is now evident that many features linked to cellular senescence, including the SASP, reflect complex changes in the activities of mTOR and other metabolic pathways. Indeed, the available evidence indicates that mTOR-dependent signaling is required for the maintenance or implementation of different aspects of cellular senescence. Thus, depending on the cell type and biological context, inhibiting mTOR in cells undergoing senescence can reverse senescence, induce quiescence or cell death, or exacerbate some features of senescent cells while inhibiting others. Interestingly, autophagy—a highly regulated catabolic process—is also commonly upregulated in senescent cells. As mTOR activation leads to repression of autophagy in non-senescent cells (mTOR as an upstream regulator of autophagy), the upregulation of autophagy observed in senescent cells must take place in an mTOR-independent manner. Notably, there is evidence that autophagy provides free amino acids that feed the mTOR complex 1 (mTORC1), which in turn is required to initiate the synthesis of SASP components. Therefore, mTOR activation can follow the induction of autophagy in senescent cells (mTOR as a downstream effector of autophagy). These functional connections suggest the existence of autophagy regulatory pathways in senescent cells that differ from those activated in non-senescence contexts. We envision that untangling these functional connections will be key for the generation of combinatorial anti-cancer therapies involving pro-senescence drugs, mTOR inhibitors, and/or autophagy inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of mTOR dependent signaling is required for maintenance of cellular senescence (15,27)”
From Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer (2023) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“In fact, dysregulation of cellular metabolism is a hallmark of cellular senescence [52], a feature partially attributed to epigenetic modifications [56].”
BackgroundmTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737 · cited 1×
“mTORC2 (containing mTOR, mSIN1, DEPTOR, and the scaffold protein RICTOR), on the other hand, orchestrates dynamic rearrangements of the cytoskeleton and the activation of pro-survival pathways in response to growth-promoting signals [68,69].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“Senescent cells also accumulate in aging tissues, contributing to the tissue and organ dysfunction that accompanies organismal aging [7,9].”
BackgroundAn Overview of Autophagy: Morphology, Mechanism, and Regulation
Parzych, K. R., & Klionsky, D. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5371 · Cited by 2,521
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“As expected, this “senescence-associated secretory phenotype (SASP)” greatly expands the effects of senescent cells arising in complex tissues [12,42,43]: while some SASP factors perpetuate, or even promote, senescence [44], others can stimulate proliferation or enhance the migration of non-senescent neighbor cells [1…”
Background
Research works printed but not linked: 128
- Tominaga, 2015, The emerging role of senescent cells in tissue homeostasis and pathophysiology, Pathobiol. Aging Age-Related Dis., 5, 27743, 10.3402/pba.v5.27743 · DOI · Paper page
- Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA, 98, 12072, 10.1073/pnas.211053698 · DOI · Paper page
- Ghosh, 2016, The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging, J. Investig. Dermatol., 136, 2133, 10.1016/j.jid.2016.06.621 · DOI · Paper page
- Ruas, 2007, CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms, Mol. Cell. Biol., 27, 4273, 10.1128/MCB.02286-06 · DOI · Paper page
- Bollard, 2016, Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma, Gut, 66, 1286, 10.1136/gutjnl-2016-312268 · DOI · Paper page
- Asby, 2018, Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity, Cancer Manag. Res., 10, 3483, 10.2147/CMAR.S167095 · DOI
- Goel, 2018, CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest, Trends Cell Biol., 28, 911, 10.1016/j.tcb.2018.07.002 · DOI · Paper page
- Chen, 2007, DNA damage, cellular senescence and organismal ageing: Causal or correlative?, Nucleic Acids Res., 35, 7417, 10.1093/nar/gkm681 · DOI · Paper page
- Saleh, T., Bloukh, S., Carpenter, V.J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., and Gewirtz, D.A. (2020). Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy. Cancers, 12. · DOI · Paper page
- Regulski, 2017, Cellular Senescence: What, Why, and How, Wounds, 29, 168
- Carnero, 2015, Disruptive chemicals, senescence and immortality, Carcinog., 36, S19, 10.1093/carcin/bgv029 · DOI · Paper page
- Lipchick, 2017, The Immortal Senescence, Methods Mol. Biology, 1534, 1, 10.1007/978-1-4939-6670-7_1 · DOI
- Sikora, 2016, Morphological and Functional Characteristic of Senescent Cancer Cells, Curr. Drug Targets, 17, 377, 10.2174/1389450116666151019094724 · DOI · Paper page
- Kanherkar, 2016, Cellular Senescence as the Causal Nexus of Aging, Front. Genet., 7, 13
- Chatsirisupachai, 2019, A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence, Aging Cell, 18, e13041, 10.1111/acel.13041 · DOI · Paper page
- Rhinn, 2019, Cellular senescence in development, regeneration and disease, Development, 146, dev151837, 10.1242/dev.151837 · DOI · Paper page
- Ohtani, 2017, The role of SASP in tumor microenvironment, Clin. Calcium, 27, 835
- Kim, 2019, Cellular senescence in cancer, BMB Rep., 52, 42, 10.5483/BMBRep.2019.52.1.295 · DOI
- Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
- Nakao, 2020, Cellular Senescence Variation by Metabolic and Epigenomic Remodeling, Trends Cell Biol., 30, 919, 10.1016/j.tcb.2020.08.009 · DOI
- Sabbatinelli, 2019, Where Metabolism Meets Senescence: Focus on Endothelial Cells, Front. Physiol., 10, 1523, 10.3389/fphys.2019.01523 · DOI · Paper page
- Serrano, 2015, The InflammTORy Powers of Senescence, Trends Cell Biol., 25, 634, 10.1016/j.tcb.2015.09.011 · DOI
- Sarbassov, 2006, Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB, Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029 · DOI · Paper page
- Yip, 2010, Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition, Mol. Cell, 38, 768, 10.1016/j.molcel.2010.05.017 · DOI · Paper page
- Su, 2017, mTORC1 senses stresses: Coupling stress to proteostasis, BioEssays, 39, 1600268, 10.1002/bies.201600268 · DOI
- Fu, W., and Hall, M.N. (2020). Regulation of mTORC2 Signaling. Genes, 11. · DOI · Paper page
- Schreiber, 2015, Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK 506-binding proteins, Aging Cell, 14, 265, 10.1111/acel.12313 · DOI · Paper page
- Betz, 2013, Where is mTOR and what is it doing there?, J. Cell Biol., 203, 563, 10.1083/jcb.201306041 · DOI · Paper page
- Puertollano, 2014, mTOR and lysosome regulation, F1000Prime Rep., 6, 52, 10.12703/P6-52 · DOI · Paper page
- Eltschinger, 2016, TOR Complexes and the Maintenance of Cellular Homeostasis, Trends Cell Biol., 26, 148, 10.1016/j.tcb.2015.10.003 · DOI · Paper page
- 2019, mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer, Front. Oncol., 9, 1373, 10.3389/fonc.2019.01373 · DOI · Paper page
- Rabanal-Ruiz, Y., and Korolchuk, V.I. (2018). mTORC1 and Nutrient Homeostasis: The Central Role of the Lysosome. Int. J. Mol. Sci., 19. · DOI · Paper page
- Wang, 2017, Activity-independent targeting of mTOR to lysosomes in primary osteoclasts, Sci. Rep., 7, 3005, 10.1038/s41598-017-03494-2 · DOI
- Caron, 2015, The Roles of mTOR Complexes in Lipid Metabolism, Annu. Rev. Nutr., 35, 321, 10.1146/annurev-nutr-071714-034355 · DOI · Paper page
- Lamming, 2013, A Central Role for mTOR in Lipid Homeostasis, Cell Metab., 18, 465, 10.1016/j.cmet.2013.08.002 · DOI · Paper page
- Chauvin, 2014, Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program, Oncogene, 33, 474, 10.1038/onc.2012.606 · DOI · Paper page
- Qin, 2016, 4E-BP1, a multifactor regulated multifunctional protein, Cell Cycle, 15, 781, 10.1080/15384101.2016.1151581 · DOI · Paper page
- Howell, 2013, A growing role for mTOR in promoting anabolic metabolism, Biochem. Soc. Trans., 41, 906, 10.1042/BST20130041 · DOI · Paper page
- Condon, 2019, Nutrient regulation of mTORC1 at a glance, J. Cell Sci., 132, jcs222570, 10.1242/jcs.222570 · DOI · Paper page
- Menon, 2008, Common corruption of the mTOR signaling network in human tumors, Oncogene, 27, S43, 10.1038/onc.2009.352 · DOI · Paper page
- Papadopoli, 2019, mTOR as a central regulator of lifespan and aging, F1000Research, 8, 998, 10.12688/f1000research.17196.1 · DOI · Paper page
- Kolesnichenko, 2012, Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence, Cell Cycle, 11, 2391, 10.4161/cc.20683 · DOI · Paper page
- Pospelova, 2013, Rapamycin induces pluripotent genes associated with avoidance of replicative senescence, Cell Cycle, 12, 3841, 10.4161/cc.27396 · DOI
- Gillespie, 2015, Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production, Nucleus, 6, 490, 10.1080/19491034.2015.1128610 · DOI
- Leontieva, 2015, Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program), Oncotarget, 6, 23238, 10.18632/oncotarget.4836 · DOI · Paper page
- Chen, 2010, Altered mTOR Signaling in Senescent Retinal Pigment Epithelium, Investig. Opthalmology Vis. Sci., 51, 5314, 10.1167/iovs.10-5280 · DOI · Paper page
- Terzi, 2016, The cell fate: Senescence or quiescence, Mol. Biol. Rep., 43, 1213, 10.1007/s11033-016-4065-0 · DOI · Paper page
- Serrano, 2010, Shifting senescence into quiescence by turning up p53, Cell Cycle, 9, 4256, 10.4161/cc.9.21.13785 · DOI · Paper page
- Leontieva, 2010, Weak p53 permits senescence during cell cycle arrest, Cell Cycle, 9, 4323, 10.4161/cc.9.21.13584 · DOI · Paper page
- Liu, 2020, Functional crosstalk between mTORC1/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs, Stem Cell Res. Ther., 11, 279, 10.1186/s13287-020-01798-1 · DOI
- Khor, 2018, Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107, Int. J. Biochem. Cell Biol., 101, 64, 10.1016/j.biocel.2018.05.016 · DOI
- Khor, 2020, The roles of MTOR and miRNAs in endothelial cell senescence, Biogerontology, 21, 517, 10.1007/s10522-020-09876-w · DOI
- Schaub, 2019, mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells, Sci. Rep., 9, 20071, 10.1038/s41598-019-56237-w · DOI
- Martin, 2015, Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation, Stem Cells, 33, 1359, 10.1002/stem.1931 · DOI
- Zheng, 2017, mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells, Int. J. Dev. Biol., 61, 65, 10.1387/ijdb.160207dz · doi:10.1387/ijdb.160207dz
- Piegari, 2013, Doxorubicin induces senescence and impairs function of human cardiac progenitor cells, Basic Res. Cardiol., 108, 334, 10.1007/s00395-013-0334-4 · DOI · Paper page
- Cesselli, 2017, Cardiac Cell Senescence and Redox Signaling, Front. Cardiovasc. Med., 4, 38, 10.3389/fcvm.2017.00038 · DOI
- Manzella, 2018, Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy, Aging Cell, 17, e12811, 10.1111/acel.12811 · DOI · Paper page
- Occhipinti, 2020, Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications, Front. Genet., 11, 349, 10.3389/fgene.2020.00349 · DOI
- Michaloglou, 2018, Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer, Mol. Cancer Ther., 17, 908, 10.1158/1535-7163.MCT-17-0537 · DOI · Paper page
- Wong, 2019, PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer, Endocr.-Relat. Cancer, 26, 425, 10.1530/ERC-19-0011 · DOI
- Song, 2018, Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma, Clin. Cancer Res., 25, 403, 10.1158/1078-0432.CCR-18-0284 · DOI
- Yamamoto, 2019, Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer, Breast Cancer Res. Treat., 174, 615, 10.1007/s10549-018-05104-9 · DOI
- Chen, 2019, Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway, Med. Sci. Monit., 25, 77, 10.12659/MSM.912929 · doi:10.12659/msm.912929
- Cretella, 2018, The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells, J. Exp. Clin. Cancer Res., 37, 72, 10.1186/s13046-018-0741-3 · DOI · Paper page
- Knudsen, 2019, Cell cycle plasticity driven by MTOR signaling: Integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer, Oncogene, 38, 3355, 10.1038/s41388-018-0650-0 · DOI
- Kumarasamy, 2020, Chemotherapy impacts on the cellular response to CDK4/6 inhibition: Distinct mechanisms of interaction and efficacy in models of pancreatic cancer, Oncogene, 39, 1831, 10.1038/s41388-019-1102-1 · DOI
- Bonelli, 2017, Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells, Neoplasia, 19, 637, 10.1016/j.neo.2017.05.003 · DOI
- Yuxiang, 2019, Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer, Cancer Biol. Med., 16, 66, 10.20892/j.issn.2095-3941.2018.0361 · DOI
- McDermott, 2020, Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer, Breast Cancer Res., 22, 89, 10.1186/s13058-020-01320-8 · DOI
- Figlia, 2020, Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1, Cell Rep., 31, 107504, 10.1016/j.celrep.2020.03.068 · DOI
- Kimmelman, 2011, The dynamic nature of autophagy in cancer, Genes Dev., 25, 1999, 10.1101/gad.17558811 · DOI · Paper page
- Yu, 2018, Autophagy pathway: Cellular and molecular mechanisms, Autophagy, 14, 207, 10.1080/15548627.2017.1378838 · DOI · Paper page
- Chen, 2010, Autophagy and tumorigenesis, FEBS Lett., 584, 1427, 10.1016/j.febslet.2009.12.034 · DOI · Paper page
- Guo, 2016, Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells, Genes Dev., 30, 1704, 10.1101/gad.283416.116 · DOI · Paper page
- Mizushima, 2011, Autophagy: Renovation of Cells and Tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
- White, 2015, Autophagy, Metabolism, and Cancer, Clin. Cancer Res., 21, 5037, 10.1158/1078-0432.CCR-15-0490 · DOI · Paper page
- Li, 2020, Autophagy and autophagy-related proteins in cancer, Mol. Cancer, 19, 12, 10.1186/s12943-020-1138-4 · DOI · Paper page
- Li, 2020, Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation, Nat. Commun., 11, 3806, 10.1038/s41467-020-17395-y · DOI · Paper page
- Bao, 2020, Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells, Cell Death Dis., 11, 223, 10.1038/s41419-020-2419-y · DOI
- White, 2019, Role of tumor and host autophagy in cancer metabolism, Genes Dev., 33, 610, 10.1101/gad.325514.119 · DOI · Paper page
- White, 2021, Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity, Trends Cancer, 7, 778, 10.1016/j.trecan.2021.05.003 · DOI
- Abada, 2014, Getting ready for building: Signaling and autophagosome biogenesis, EMBO Rep., 15, 839, 10.15252/embr.201439076 · DOI · Paper page
- Wen, 2016, An overview of macroautophagy in yeast, J. Mol. Biol., 428, 1681, 10.1016/j.jmb.2016.02.021 · DOI · Paper page
- Saftig, 2016, Turn up the lysosome, Nat. Cell Biol., 18, 1025, 10.1038/ncb3409 · DOI
- Kraft, 2012, Mechanisms and regulation of autophagosome formation, Curr. Opin. Cell Biol., 24, 496, 10.1016/j.ceb.2012.05.001 · DOI
- Kawabata, 2020, Autophagosome biogenesis and human health, Cell Discov., 6, 33, 10.1038/s41421-020-0166-y · DOI
- Yang, 2009, An Overview of the Molecular Mechanism of Autophagy, Curr. Top. Microbiol. Immunol., 335, 1
- Schmeisser, 2019, Pleiotropic Effects of mTOR and Autophagy during Development and Aging, Front. Cell Dev. Biol., 7, 192, 10.3389/fcell.2019.00192 · DOI · Paper page
- Kim, 2013, Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy, Cell, 152, 290, 10.1016/j.cell.2012.12.016 · DOI · Paper page
- Nazio, 2013, mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6, Nat. Cell Biol., 15, 406, 10.1038/ncb2708 · DOI · Paper page
- Yuan, 2013, Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy, Autophagy, 9, 1983, 10.4161/auto.26058 · DOI · Paper page
- Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J., 31, 1095, 10.1038/emboj.2012.32 · DOI · Paper page
- Kim, 2011, Regulation of the autophagy initiating kinase ULK1 by nutrients: Roles of mTORC1 and AMPK, Cell Cycle, 10, 1337, 10.4161/cc.10.9.15291 · DOI
- Ganley, 2009, ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy, J. Biol. Chem., 284, 12297, 10.1074/jbc.M900573200 · DOI · Paper page
- Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, 8, 903, 10.4161/auto.19653 · DOI · Paper page
- Petit, 2012, The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis, Sci. Signal., 5, ra42
- Lim, 2016, The lysosome as a command-and-control center for cellular metabolism, J. Cell Biol., 214, 653, 10.1083/jcb.201607005 · DOI · Paper page
- Xu, 2020, Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways, Ann. N. Y. Acad. Sci., 1467, 3, 10.1111/nyas.14305 · DOI · Paper page
- Wyant, 2017, Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes, Science, 358, 807, 10.1126/science.aan6298 · DOI · Paper page
- Shen, J., Wu, G., and Guo, S. (2021). Amino Acids in Autophagy: Regulation and Function. Amino Acids in Nutrition and Health, Springer. · DOI
- Angarola, 2020, Coordination of Rheb lysosomal membrane interactions with mTORC1 activation, F1000Research, 9, 450, 10.12688/f1000research.22367.1 · DOI
- Deng, 2019, Ubiquitination of Rheb governs growth factor-induced mTORC1 activation, Cell Res., 29, 136, 10.1038/s41422-018-0120-9 · DOI
- Abraham, 2010, Lysosomal Rag-ulation of mTOR Complex 1 Activity, Cell Metab., 11, 341, 10.1016/j.cmet.2010.04.010 · DOI
- Mu, 2017, Structural insight into the Ragulator complex which anchors mTORC1 to the lysosomal membrane, Cell Discov., 3, 17049, 10.1038/celldisc.2017.49 · DOI · Paper page
- Brady, 2016, Rags to riches: Amino acid sensing by the Rag GTPases in health and disease, Small GTPases, 7, 197, 10.1080/21541248.2016.1218990 · DOI
- Kwon, 2017, Autophagy Is Pro-Senescence When Seen in Close-Up, but Anti-Senescence in Long-Shot, Mol. Cells, 40, 607, 10.14348/molcells.2017.0151 · DOI · Paper page
- Slobodnyuk, 2019, Autophagy-induced senescence is regulated by p38α signaling, Cell Death Dis., 10, 376, 10.1038/s41419-019-1607-0 · DOI · Paper page
- Bernard, 2020, Autophagy drives fibroblast senescence through MTORC2 regulation, Autophagy, 16, 2004, 10.1080/15548627.2020.1713640 · DOI · Paper page
- Rastaldo, 2020, Dual Role of Autophagy in Regulation of Mesenchymal Stem Cell Senescence, Front. Cell Dev. Biol., 8, 276, 10.3389/fcell.2020.00276 · DOI
- Carroll, 2017, Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing, J. Cell Biol., 216, 1949, 10.1083/jcb.201610113 · DOI · Paper page
- Carroll, 2018, Nutrient sensing, growth and senescence, FEBS J., 285, 1948, 10.1111/febs.14400 · DOI · Paper page
- Liu, 2019, Cellular Senescence-Inducing Small Molecules for Cancer Treatment, Curr. Cancer Drug Targets, 19, 109, 10.2174/1568009618666180530092825 · DOI
- Bojko, A., Czarnecka-Herok, J., Charzynska, A., Dabrowski, M., and Sikora, E. (2019). Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents. Cells, 8. · DOI · Paper page
- Dunlop, 2014, mTOR and autophagy: A dynamic relationship governed by nutrients and energy, Semin. Cell Dev. Biol., 36, 121, 10.1016/j.semcdb.2014.08.006 · DOI · Paper page
- Carroll, 2017, The lysosome: A crucial hub for AMPK and mTORC1 signalling, Biochem. J., 474, 1453, 10.1042/BCJ20160780 · DOI · Paper page
- Dossou, A.S., and Basu, A. (2019). The Emerging Roles of mTORC1 in Macromanaging Autophagy. Cancers, 11. · DOI · Paper page
- Payea, 2020, Translational Control during Cellular Senescence, Mol. Cell. Biol., 41, e00512-20, 10.1128/MCB.00512-20 · DOI · Paper page
- Brown, 2012, Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium, Cancer Res., 72, 6477, 10.1158/0008-5472.CAN-11-4139 · DOI · Paper page
- Valenzuela, 2017, Palbociclib-induced autophagy and senescence in gastric cancer cells, Exp. Cell Res., 360, 390, 10.1016/j.yexcr.2017.09.031 · DOI · Paper page
- Okada, 2017, Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines, Oncol. Rep., 38, 31, 10.3892/or.2017.5684 · DOI
- Vijayaraghavan, 2017, CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers, Nat. Commun., 8, 15916, 10.1038/ncomms15916 · DOI · Paper page
- Chittaranjan, 2014, Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer, Clin. Cancer Res., 20, 3159, 10.1158/1078-0432.CCR-13-2060 · DOI · Paper page
- Lefort, 2014, Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers, Autophagy, 10, 2122, 10.4161/15548627.2014.981788 · DOI · Paper page
- Gewirtz, 2013, Autophagy and senescence in cancer therapy, J. Cell. Physiol., 229, 6
- Patel, 2020, The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation, Radiat. Res., 194, 103, 10.1667/RADE-20-00009 · DOI
- Goehe, 2012, The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?, J. Pharmacol. Exp. Ther., 343, 763, 10.1124/jpet.112.197590 · DOI
- Pawlowska, E., Szczepanska, J., Szatkowska, M., and Blasiak, J. (2018). An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme—Role in Pathogenesis and Therapeutic Perspective. Int. J. Mol. Sci., 19. · DOI
Cited by
Skin aging from mechanisms to interventions: focusing on dermal aging
Shin, S. H., Lee, Y. H., Rho, N.-K., & Park, K. Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1195272 · Cited by 295
Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Yaeger, R., Mezzadra, R., Sinopoli, J., Bian, Y., Marasco, M., Kaplun, E., Gao, Y., Zhao, H., Paula, A. D. C., Zhu, Y., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0405 · Cited by 144
“Based on these data, combination treatments based on KRAS inhibitors and EGFR”
Metadata
- Authors
- Cayo, A., Segovia, R., Venturini, W., Moore-Carrasco, R., Valenzuela, C., & Brown, N.
- Affiliations
- Center for Medical Research, University of Talca School of Medicine, Talca 346000, Chile
- Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca 346000, Chile
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-07-29
- Volume
- 22
- Issue
- 15
- Pages
- 8149
- ISSN
- 1422-0067
- Cited by
- 93
- References
- 80
- Language
- en
- Funders
- Fondo Nacional de Desarrollo Científico y Tecnológico (11201182)
- Programa de Investigación Asociativa en Cáncer Gástrico (PIA-CG, RU2107)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.